Vertex Pharmaceuticals Inc
VRTX
ISIN null / Valor 983327
Vertex Pharmaceuticals Inc
UMushroom community rating:
About company
Vertex Pharmaceuticals Inc. is a global biotechnology firm focused on developing and commercializing innovative treatments for serious diseases. With headquarters in Boston and London, the company operates a network of research and development sites along with commercial offices worldwide. Vertex Pharmaceuticals is known for its commitment to scientific innovation, aiming to address unmet medical needs in various therapeutic areas. While the source does not specify the diseases or treatments the company focuses on, Vertex has gained recognition for its work in cystic fibrosis (CF) and other life-threatening conditions, developing a range of medications that have significantly impacted patients' lives. The company's global presence and dedication to transformative treatments underscore its role in the biotech industry, striving to improve health outcomes for patients facing serious diseases.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
126212 M
Market cap (USD)
1,782,950
Daily traded volume (Shares)
407.06 / 399.11
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
Wanja Staubli
EQUITIES OF THE SAME SECTOR
